home / stock / cocp / cocp news


COCP News and Press, Cocrystal Pharma Inc. From 11/25/20

Stock Information

Company Name: Cocrystal Pharma Inc.
Stock Symbol: COCP
Market: NASDAQ
Website: cocrystalpharma.com

Menu

COCP COCP Quote COCP Short COCP News COCP Articles COCP Message Board
Get COCP Alerts

News, Short Squeeze, Breakout and More Instantly...

COCP - AnPac Bio-Medical, Cocrystal Pharma leads healthcare gainers; Hepion Pharmaceuticals, Medigus among major losers

Gainers: AnPac Bio-Medical Science (ANPC) +110%, Cocrystal Pharma (COCP) +56%, Renalytix AI (RNLX) +31%, Precigen (PGEN) +13%, Chiasma (CHMA) +11%.Losers: Hepion Pharmaceuticals (HEPA) -29%, Medigus (MDGS) -12%, Retractable Technologies (...

COCP - Microcaps mostly among premarket gainers

AnPac Bio-Medical Science (ANPC) +95% on Q3 record test volume.Mmtec (MTC) +50%.Yunji (YJ) +46% on deal with Bytedance's live streaming platform.Weidai (WEI) +30%.Safe-T Group Ltd (SFET) +22% on Q3 results.Molecular Data (MKD) +22%.21Vianet Group (VNET) +20%...

COCP - What Are The Best Penny Stocks To Buy Now? 2 With 46%-284% Targets

Are Analysts Right About Some Of These Penny Stocks? After several weeks of rallies in the stock market, investors are continuing to pay attention to penny stocks . On November 24th, the stock market had one of the best days in months. Tuesday saw the Dow Jones Industrial Average sh...

COCP - Cocrystal Pharma misses on revenue

Cocrystal Pharma (COCP): Q3 GAAP EPS of -$0.05.Revenue of $0.49M (flat Y/Y) misses by $0.09M.Shares +0.3% PM.10QPress Release For further details see: Cocrystal Pharma misses on revenue

COCP - Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs

– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical molecule selection expected by year end – – Ongoing Merck collaboration to discover and develop i...

COCP - Cocrystal Pharma Selected to Present at the World Antiviral Conference

BOTHELL, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announ...

COCP - Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference

– Live video webcast with the Cocrystal management team, on Thursday, November 12 th at 12:00 PM EST – BOTHELL, WA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”),...

COCP - Cocrystal Pharma Provides Update on Influenza A Program

– New in vitro data demonstrating antiviral activity with lead compound CC-42344 against Xofluza (baloxavir)-resistant H1N1 strain – – Company continues to advance IND-enabling studies for Phase 1 clinical study in 2021 – BOTHELL, WA, Oc...

COCP - 6 Penny Stocks Under $1.50 To Watch Before Tomorrow Morning

Penny Stocks Under $1 To Watch Right Now; 1 Up Over 65% After-Hours Penny stocks come in all shapes and sizes. They range anywhere from the cheapest penny stocks at $0.0001 to the high end of $4.9999. Whether you’re buying the cheapest of these or the “most expensi...

COCP - Cocrystal Pharma Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

BOTHELL, WA, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP) The following is being released by Cocrystal Pharma, Inc. pursuant to an order of the United States District Court, District of New Jersey, regarding Agreement of Settlement. UNITED STA...

Previous 10 Next 10